Save time and get answers to complex questions with AI chat
Is clarinex off patent?Can wine consumption affect lipitor's cholesterol lowering ability?Dabrafenib btd date 2023?Is allopurinol expensive?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for Vowst
Vowst (fecal microbiota, live-jslm) is a treatment for C. difficile infection (C. diff). It is intended for people with recurrent C. diff, not for a first-episode infection.
Vowst is used after C. diff has been treated and then the infection comes back, which is why it’s specifically discussed in the context of recurrent C. diff.
Vowst contains live fecal microbiota intended to help restore a healthier gut microbial balance after antibiotics and C. diff treatment, reducing the chance of further recurrence.
No. Recurrent C. diff is also managed with other approaches (such as additional antibiotic strategies and other fecal microbiota–based options depending on availability and eligibility). Vowst is one option specifically labeled for recurrent C. diff.
Other Questions About Vowst :